Evidence for Peripheral Immune Activation in Parkinson’s Disease
Authors:
Open Access
- 30 April 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 13
Abstract
Background: Accumulating evidence has revealed that peripheral immunity is involved in Parkinson’s disease (PD). However, the results regarding the percentage of T-cell subsets are inconsistent, and the changes of immunoglobins levels have been seldom studied in PD patients.Methods: Serum levels of the percentage of T-cell subsets and immunoglobulins were measured in 761 PD patients and 761 age- and gender-matched healthy controls. The correlations between the variables of peripheral immune activation (PIA) and the clinical characteristics of PD were analyzed using correlation analysis.Results: The pooled results showed that PD patients had higher proportional levels of CD3+ T and CD4+ T lymphocytes than healthy controls. CD8+ T cell percentages were similar in PD patients and controls, and the CD4/CD8 ratio was significantly higher in the PD population. No significant differences in IgG, IgA, or IgM levels between these two groups were found. CD4+ T cell percentage was inversely correlated with the H&Y stage, and IgG level was positively correlated with disease duration and UPDRS part III. Subgroup analyses showed that these associations existed in female patients, but not in male patients.Conclusion: The enhanced immune activation in the peripheral system is indicated in PD, and dynamic alterations in CD4+ T cell percentage and IgG level suggest an active role for peripheral immunity in the disease progression, especially in female PD patients.Keywords
This publication has 53 references indexed in Scilit:
- MHCII Is Required for -Synuclein-Induced Activation of Microglia, CD4 T Cell Proliferation, and Dopaminergic NeurodegenerationThe Journal of Neuroscience, 2013
- Natural IgG Autoantibodies Are Abundant and Ubiquitous in Human Sera, and Their Number Is Influenced By Age, Gender, and DiseasePLOS ONE, 2013
- Neuroimmunological Processes in Parkinson’s Disease and their Relation to α-Synuclein: Microglia as the Referee between Neuronal Processes and Peripheral ImmunityASN Neuro, 2013
- Diagnosis of Parkinson's Disease Based on Disease-Specific Autoantibody Profiles in Human SeraPLOS ONE, 2012
- Fcγ receptors are required for NF-κB signaling, microglial activation and dopaminergic neurodegeneration in an AAV-synuclein mouse model of Parkinson's diseaseMolecular Neurodegeneration, 2010
- Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson diseaseJournal of Clinical Investigation, 2008
- Targeted Overexpression of Human α-Synuclein Triggers Microglial Activation and an Adaptive Immune Response in a Mouse Model of Parkinson DiseaseJournal of Neuropathology & Experimental Neurology, 2008
- Autoantibodies to alpha‐synuclein in inherited Parkinson’s diseaseJournal of Neurochemistry, 2006
- Pattern of brain destruction in Parkinson's and Alzheimer's diseasesJournal of Neural Transmission, 1996
- ParkinsonismNeurology, 1967